Allogeneic blood transfusion and prognosis following total hip replacement: A population-based follow up study

BMC Musculoskeletal Disorders

Volumn 10, Issue , 2009, Pages

  Pedersen, Alma B ^a   Mehnert, Frank ^a   Overgaard, Soren ^b   Johnsen, Soren P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHILD; CONTROLLED STUDY; DATA BASE; DENMARK; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PROGNOSIS; REOPERATION; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SURGICAL TECHNIQUE; VENOUS THROMBOEMBOLISM; ALLOTRANSPLANTATION; BLOOD TRANSFUSION; COHORT ANALYSIS; HIGH RISK BEHAVIOR; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RISK; RISK FACTOR; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RISK FACTORS; RISK-TAKING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74949085046     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-10-167     Document Type: Article

References (37)

1. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences. LS Lohmander LB Engesaeter P Herberts T Ingvarsson U Lucht TJ Puolakka, Acta Orthop 2006 77 733 740 10.1080/17453670610012917 17068703
2. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. NN Mahomed JA Barrett JN Katz CB Phillips E Losina RA Lew E Guadagnoli WH Harris R Poss JA Baron, J Bone Joint Surg Am 2003 85-A 27 32 12533568
3. Total hip arthroplasty in Denmark. Incidence of primary operations and revisions 1996-2002 and estimated future demands. AB Pedersen SP Johnsen S Overgaard K Soballe HT Sorensen U Lucht, Acta Orthopaedica 2005 76 182 189 10.1080/00016470510030553 16097542
4. Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions. PB Hasley JR Lave BH Hanusa VC Arena G Ramsey WN Kapoor MJ Fine, Med Care 1995 33 1145 1160 10.1097/00005650-199511000- 00007 7475423
5. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group, Transfusion Medicine 1994 4 251 268 10.1111/j.1365-3148. 1994.tb00262.x 7889138
6. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. CG Koch L Li AI Duncan T Mihaljevic DM Cosgrove FD Loop NJ Starr EH Blackstone, Crit Care Med 2006 34 1608 1616 10.1097/01.CCM.0000217920.48559.D8 16607235
7. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. M Kuduvalli AY Oo N Newall AD Grayson M Jackson MJ Desmond BM Fabri A Rashid, Eur J Cardiothorac Surg 2005 27 592 598 10.1016/j.ejcts.2005.01.030 15784356
8. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. DL Malone J Dunne JK Tracy AT Putnam TM Scalea LM Napolitano, J Trauma 2003 54 898 905 10.1097/01.TA.0000060261.10597.5C 12777902
9. Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. WP Robinson III J Ahn A Stiffler EJ Rutherford H Hurd BL Zarzaur CC Baker AA Meyer PB Rich, J Trauma 2005 58 437 444 10.1097/01.TA.0000153935.18997.14 15761334
10. Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. AM Audet C Andrzejewski MA Popovsky, Orthopedics 1998 21 851 858 9731667 (Pubitemid 28407067)
11. An analysis of blood management in patients having a total hip or knee arthroplasty. BE Bierbaum JJ Callaghan JO Galante HE Rubash RE Tooms RB Welch, J Bone Joint Surg Am 1999 81 2 10 9973048
12. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. JL Carson DG Altman A Duff H Noveck MP Weinstein FA Sonnenberg JI Hudson G Provenzano, Transfusion 1999 39 694 700 10.1046/j.1537-2995.1999.39070694.x 10413276
13. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. JR Dunne DL Malone JK Tracy LM Napolitano, Surg Infect (Larchmt) 2004 5 395 404 10.1089/sur.2004.5.395 15744131
14. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. P Innerhofer A Klingler C Klimmer D Fries W Nussbaumer, Transfusion 2005 45 103 110 10.1111/j.1537-2995.2005.04149.x 15647025
15. Is perioperative blood transfusion a risk factor for mortality or infection after hip fracture? P Johnston H Wynn-Jones D Chakravarty A Boyle MJ Parker, J Orthop Trauma 2006 20 675 679 10.1097/01.bot.0000249435.25751.e8 17106377
16. Registration in the Danish Hip Arthroplasty Registry: Completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. A Pedersen S Johnsen S Overgaard K Soballe H Sorensen U Lucht, Acta Orthop Scand 2004 75 434 441 15370588
17. The Danish Civil Registration System. A cohort of eight million persons. CB Pedersen H Gotzsche JO Moller PB Mortensen, Dan Med Bull 2006 53 441 449 17150149
18. Variable selection for propensity score models. MA Brookhart S Schneeweiss KJ Rothman RJ Glynn J Avorn T Sturmer, Am J Epidemiol 2006 163 1149 1156 10.1093/aje/kwj149 16624967
19. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. RB D'Agostino Jr, Stat Med 1998 17 2265 2281 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0. CO;2-B 9802183
20. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. ME Charlson P Pompei KL Ales CR MacKenzie, J Chronic Dis 1987 40 373 383 10.1016/0021-9681(87)90171-8 3558716
21. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. AM Joensen MK Jensen K Overvad C Dethlefsen E Schmidt L Rasmussen A Tjonneland S Johnsen, J Clin Epidemiol 2009 62 188 194 10.1016/j.jclinepi.2008.03.005 18722087
22. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. RW Thomsen HH Hundborg HH Lervang SP Johnsen HT Sorensen HC Schonheyder, Diabetes Care 2004 27 70 76 10.2337/diacare.27.1.70 14693969
23. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. RW Thomsen A Riis M Norgaard J Jacobsen S Christensen CJ McDonald HT Sorensen, J Intern Med 2006 259 410 417 10.1111/j.1365-2796.2006.01629.x 16594909
24. The predictive value of ICD-10 diagnoses in population-based hospital registries used to assess Charlson Comorbidity Index. SK Thygesen CF Christiansen TL Lash S Christensen HT Sorensen, Pharmacoepidemiology and drug safety 2009 18 Suppl 1 189
25. Danish Medicines Agency, Redegørelse for blodproduktområdet 2007. Copenhagen 2008
26. [Transfusion practice in total hip arthroplasty in Danish departments of orthopaedic surgery]. AB Pedersen F Mehnert S Overgaard B Moller SP Johnsen, Ugeskr Laeger 2009 171 973 977 19284915
27. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. R Rana ER Fernandez-Perez SA Khan S Rana JL Winters TG Lesnick SB Moore O Gajic, Transfusion 2006 46 1478 1483 10.1111/j.1537-2995.2006.00930.x 16965572
28. Survival following total hip replacement. J Barrett E Losina JA Baron NN Mahomed J Wright JN Katz, J Bone Joint Surg Am 2005 87 1965 1971 10.2106/JBJS.D.02440 16140810
29. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. CG Koch L Li AI Duncan T Mihaljevic FD Loop NJ Starr EH Blackstone, Ann Thorac Surg 2006 81 1650 1657 10.1016/j.athoracsur.2005.12.037 16631651
30. Duration of red-cell storage and complications after cardiac surgery. CG Koch L Li DI Sessler P Figueroa GA Hoeltge T Mihaljevic EH Blackstone, N Engl J Med 2008 358 1229 1239 10.1056/NEJMoa070403 18354101
31. Blood transfusion and septic complications after hip replacement surgery. EC Vamvakas SB Moore M Cabanela, Transfusion 1995 35 150 156 10.1046/j.1537-2995.1995.35295125738.x 7825211
32. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM). EC Vamvakas, Crit Care Med 2006 34 151 S159 10.1097/01.CCM.0000214310.70642.8C 16617260
33. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. PE Marik HL Corwin, Crit Care Med 2008 36 2667 2674 10.1097/CCM.0b013e3181844677 18679112
34. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Aderinto IJ Brenkel, J Bone Joint Surg Br 2004 86 970 973 10.1302/0301-620X.86B7.14682 15446520
35. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. E Pola P Papaleo A Santoliquido G Gasparini L Aulisa SE De, J Bone Joint Surg Am 2004 86-A 57 61 14711946
36. Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. I Singla M Zahid CB Good A Macioce AF Sonel, Am J Cardiol 2007 99 1119 1121 10.1016/j.amjcard.2006.11.056 17437739
37. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. PC Hebert G Wells MA Blajchman J Marshall C Martin G Pagliarello M Tweeddale I Schweitzer E Yetisir, N Engl J Med 1999 340 409 417 10.1056/NEJM199902113400601 9971864